loadpatents
Patent applications and USPTO patent grants for Fishkin; Nathan Elliott.The latest application filed is for "conjugates comprising cell-binding agents and cytotoxic agents".
Patent | Date |
---|---|
Conjugates Comprising Cell-binding Agents And Cytotoxic Agents App 20210299271 - Fishkin; Nathan Elliott ;   et al. | 2021-09-30 |
Novel Benzodiazepine Derivatives App 20210238301 - Li; Wei ;   et al. | 2021-08-05 |
Conjugates comprising cell-binding agents and cytotoxic agents Grant 10,988,531 - Fishkin , et al. April 27, 2 | 2021-04-27 |
Benzodiazepine derivatives Grant 10,947,315 - Li , et al. March 16, 2 | 2021-03-16 |
Cytotoxic benzodiazepine derivatives Grant 10,570,212 - Li , et al. Feb | 2020-02-25 |
Novel Benzodiazepine Derivatives App 20190276552 - Li; Wei ;   et al. | 2019-09-12 |
Cytotoxic Benzodiazepine Derivatives App 20190263924 - Li; Wei ;   et al. | 2019-08-29 |
Methods of preparation of conjugates Grant 10,364,294 - Fishkin , et al. | 2019-07-30 |
Benzodiazepine derivatives Grant 10,208,127 - Li , et al. Feb | 2019-02-19 |
Cytotoxic benzodiazepine derivatives Grant 10,179,818 - Li , et al. Ja | 2019-01-15 |
Novel Benzodiazepine Derivatives App 20180355055 - Li; Wei ;   et al. | 2018-12-13 |
Novel Benzodiazepine Derivatives App 20180079823 - Li; Wei ;   et al. | 2018-03-22 |
Methods Of Preparation Of Conjugates App 20180037659 - Fishkin; Nathan Elliott ;   et al. | 2018-02-08 |
Methods of preparation of conjugates Grant 9,868,791 - Fishkin , et al. January 16, 2 | 2018-01-16 |
Cytotoxic Benzodiazepine Derivatives App 20180002440 - Li; Wei ;   et al. | 2018-01-04 |
Cytotoxic benzodiazepine derivatives Grant 9,840,564 - Li , et al. December 12, 2 | 2017-12-12 |
Novel Benzodiazepine Derivatives App 20170183419 - Li; Wei ;   et al. | 2017-06-29 |
Cytotoxic Benzodiazepine Derivatives App 20170044266 - Li; Wei ;   et al. | 2017-02-16 |
Benzodiazepine derivatives Grant 9,550,787 - Li , et al. January 24, 2 | 2017-01-24 |
Methods Of Preparation Of Conjugates App 20160324980 - Fishkin; Nathan Elliott ;   et al. | 2016-11-10 |
Cytotoxic benzodiazepine derivatives Grant 9,434,748 - Li , et al. September 6, 2 | 2016-09-06 |
Novel Benzodiazepine Derivatives App 20160222013 - Li; Wei ;   et al. | 2016-08-04 |
Cytotoxic Benzodiazepine Derivatives App 20160108129 - Li; Wei ;   et al. | 2016-04-21 |
Conjugates Comprising Cell-binding Agents And Cytotoxic Agents App 20160095938 - Fishkin; Nathan Elliott ;   et al. | 2016-04-07 |
Benzodiazepine derivatives Grant 9,265,841 - Li , et al. February 23, 2 | 2016-02-23 |
Cytotoxic benzodiazepine derivatives Grant 9,169,272 - Li , et al. October 27, 2 | 2015-10-27 |
Cytotoxic Benzodiazepine Derivatives App 20150099874 - Li; Wei ;   et al. | 2015-04-09 |
Novel Benzodiazepine Derivatives App 20150030616 - Li; Wei ;   et al. | 2015-01-29 |
Cytotoxic benzodiazepine derivatives Grant 8,889,669 - Li , et al. November 18, 2 | 2014-11-18 |
Benzodiazepine derivatives Grant 8,809,320 - Li , et al. August 19, 2 | 2014-08-19 |
Benzodiazepine derivatives Grant 8,802,667 - Li , et al. August 12, 2 | 2014-08-12 |
Novel Benzodiazepine Derivatives App 20130302357 - Li; Wei ;   et al. | 2013-11-14 |
Cytotoxic Benzodiazepine Derivatives App 20130302359 - Li; Wei ;   et al. | 2013-11-14 |
Novel Benzodiazepine Derivatives App 20130266596 - Li; Wei ;   et al. | 2013-10-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.